-
Enterprise Plenary Session III
Sofia Venceslau (Ph.D.)Done
-
Oral Session II B
Margarida CarvalhoDone
-
Coffee break
Done
-
Hot Topics II: New biomolecules: Challenges in the development and clinical translation
Carlos Neto, PharmD: Medical Scientific Liaison at Angelini Pharma Portugal and Pedro Madureira, Co-founder and CSO at IMMUNETHEPDone
-
Plenary Session IV
Professor Jens PahnkeDone
-
Flash Session III (A)
Inês SerrenhoDone
-
Flash Session III (B)
Andreia MagalhãesDone
-
Flash Session I (D)
Natanael FernandesDone
-
Oral Session I B
Diana PereiraDone
-
Oral Session II C
Gabriela MartinsDone
Oral Session I A
13/02/2023, 16:00
-
13/02/2023, 16:20
(UTC)
(20 minutes)
Cristiana Mateus
